Objective-Phospholipid transfer protein (PLTP) accelerates the development of atherosclerosis in mouse models. We examined the role of PLTP in atherosclerotic plaque stability. Approach and Results-We prepared apolipoprotein E and PLTP double-knockout (PLTP −/− ApoE −/− ) mice. PLTP deficiency significantly decreased lesion size and reduced monocyte/macrophage infiltration, as well as macrophage apoptosis in lesion areas. Moreover, it increased fibrous content in plaques, which suggests that PLTP may affect atherosclerotic plaque stability. Importantly, PLTP overexpression mediated by adenovirus had the reverse effect. It promoted the accumulation of reactive oxygen species in macrophages, which could lead to cell apoptosis and increased the production of inflammatory cytokines and chemokines. PLTP overexpression could promote receptor-interacting protein 3 recruitment of macrophages in cytoplasm, which could induce reactive oxygen species, thus inducing atherogenesis. 
I n the past 10 years, most human studies, including a recent Framingham Heart study, showed a positive association of plasma phospholipid transfer protein (PLTP) activity and coronary heart disease. [1] [2] [3] [4] [5] [6] [7] In mouse models, systemic PLTP deficiency reduces atherosclerosis, 8 but its overexpression has the opposite effect. [9] [10] [11] Systemic PLTP deficiency in mice is also associated with a reduced thrombotic response 12 and reduced abdominal aortic aneurysm. 13 In rabbits, overexpression of PLTP-increased atherosclerotic lesions after a high-fat diet feeding when compared with controls. 14 In general, PLTP is a risk factor of atherosclerosis in animal models. However, whether PLTP can affect the stability of atherosclerotic plaque and the mechanism involved are still unknown.
Macrophages play an important role in atherosclerotic plaque destabilization 15 and highly express PLTP. 16 Apoptotic macrophages, especially in advanced plaques, promote several processes that contribute to plaque instability. 17 PLTP could augment apoptosis in THP-1 (human acute monocytic leukemia cell line) cell-derived macrophages 18 and PLTP stimulates Janus family kinase 2 phosphorylation, 19 involved in apoptosis in several cells, including macrophages. 20 Therefore, PLTP-related plaque instability may be mediated by macrophage apoptosis.
In this study, we evaluated the association of PLTP and atherosclerotic plaque stability under PLTP-deficient and PLTPoverexpression conditions. PLTP deficiency could stabilize plague, and PLTP overexpression had the opposite effect. Furthermore, we explored the underlying mechanisms.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Adenovirus Can Mediate PLTP Expression in Carotid Arteries
To evaluate whether intravenous adenovirus transduction could mediate gene expression in carotid arteries, we injected Ad-GFP or Ad-PLTP into apolipoprotein E (ApoE) −/− or ApoE −/− /PLTP −/− mice and found that green fluorescent protein, thus PLTP, expressed in the tissue ( Figure IA in the online-only Data Supplement); as well, PLTP activity could be detected in mouse blood ( Figure IB in the onlineonly Data Supplement).
PLTP Increases Atherosclerosis
To evaluate the effect of PLTP on atherogenesis, we dissected mouse carotid arteries and found plaque area lower in PLTP −/− ApoE −/− +Ad-GFP than in ApoE −/− + Ad-GFP arteries. After Ad-PLTP transduction, plaque area was increased in both mouse groups ( Figure 1A and 1D) . We then stained carotid arteries with hematoxylin and eosin and found smaller plaque area in PLTP −/− /ApoE −/− ApoE −/− mice (P<0.05), which was increased in both mouse groups with Ad-PLTP transduction (P<0.05) when compared with controls ( Figure 1B and  1D Figure 1C and 1E). Therefore, PLTP accelerated the development of atherosclerotic plaque.
PLTP Decreases Atherosclerotic Plaque Stability
We next sought to determine whether PLTP plays a role in atherosclerotic plaque stability. The relative content of collagen, lipids, smooth muscle cells (SMCs), and macrophages in plaques was measured by histological or immunohistochemical staining. Collagen and SMC content were higher, and macrophage content was lower in PLTP To elucidate the involvement of PLTP in atherosclerosis further, we investigated cell apoptosis by TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assay. Colocalization of apoptotic cells and macrophages showed that apoptosis mainly occurred where macrophages aggregated ( Figure 2F ). Cell apoptosis, as determined by cleaved caspase-3 staining, was lower in PLTP −/− ApoE −/− mice than in ApoE −/− mice but increased with Ad-PLTP rather than with Ad-GFP transduction ( Figure 2G ). PLTP deficiency significantly decreased but overexpression increased the proportion of apoptotic cells in plaque (P<0.05; Figure 2H ). Flow cytometry also showed similar results in peritoneal macrophages ( Figure II in the online-only Data Supplement). Thus, PLTP destabilized plaques by increasing inflammatory cytokines activity and promoting macrophage apoptosis.
Effect of PLTP on Oxidative Stress
The concentration of reactive oxygen species (ROS) was lower in peritoneal macrophages and bone marrow-derived macrophages from PLTP Figure 3C ).
Effect of PLTP Macrophage Inflammatory Responses and Apoptosis
Protein levels of MCP-1, intercellular adhesion molecule-1, and MMP-9 were lower in PLTP Compared with controls, treatment with N-acetyl-l-cysteine (NAC; the ROS scavenger) alone had no significant effect on the activity of inflammatory cytokines and cleaved caspase-3 in peritoneal macrophages and bone marrow-derived macrophages, which was increased with PLTP overexpression plus NAC treatment (P<0.05; Figure 4C ; Figure IIIB in the online-only Data Supplement). Treatment with BAY 11 to 7082 (an anti-inflammatory agent) and Z-VAD-Fmk (an irreversible general caspase inhibitor) could reverse the PLTP effect (P<0.05; Figure 4D ), which again suggests that PLTP is involved in both inflammation and apoptosis.
PLTP Regulated Cleaved Caspase-3 Expression by the Receptor-Interacting Protein 3-ROS Pathway
The receptor-interacting protein 3 (RIP3) has emerged as a critical regulator of apoptosis and ROS production is its downstream event. We found RIP3 level lower in PLTP Figure 5B and 5C). Similarly, RIP3 siRNA knockdown significantly inhibited the PLTP-increased ROS production (P<0.05; Figure 5D ).
Nuclear Localization of RIP3 Aided PLTP Regulation of Cell Apoptosis
RIP3 was localized mainly in the nucleus with leptomycin B treatment and was recruited to the cytoplasm with PLTP treatment ( Figure 6A ). Nucleocytoplasmic shuttling of RIP3 could significantly change the level of cleaved caspase-3 with leptomycin B and PLTP treatment ( Figure 6B ).
Plasma Lipid, Inflammatory Cytokine, and Chemokine Levels in PLTP-Deficient and PLTP-Overexpressed Mice
We measured the lipid levels and body weight in all groups of mice and found that PLTP deficiency reduced cholesterol, triglyceride, and high-density lipoprotein (HDL) cholesterol levels in the blood; body weight showed similar results ( Table  I in the online-only Data Supplement). We measured MCP-1, tumor necrosis factor-α, and interleukin (IL)-6 in blood, and we found that PLTP deficiency reduced MCP-1 and IL-6 but not tumor necrosis factor-α levels; PLTP overexpression reversed the effect (Table II in 
Discussion
We found that PLTP overexpression could destabilize atherosclerotic plaque by reducing the local plaque content of collagen and SMCs and increasing intracellular levels of oxidants and macrophage apoptosis ( Figure VI in the onlineonly Data Supplement). Vulnerable plaque is the pathological basis of various cardiovascular clinical events. Apoptosis of macrophages within plaque is one of the most important mechanisms leading to atherosclerotic plaque instability. We aimed to investigate the role of PLTP in the pathogenesis of atherosclerosis stability and the potential mechanism of PLTP-destabilizing atherosclerotic plaque. PLTP affected atherogenicity, which led to pathological changes such as increased atherosclerotic lesions; changed content of collagen, SMCs, and macrophages and inflammation activity in plaques; augmented apoptosis-related indexes and apoptotic macrophages; increased RIP3 and ROS levels; and changed RIP3 nuclear localization.
Emerging evidence suggests that elevated plasma PLTP levels increase the number of atherosclerotic lesions, 11 and PLTP deficiency protects against atherosclerosis. 8 Most of our knowledge of PLTP regulating the atherosclerotic process is derived from studies focusing on the formation of atherosclerotic plaque. The involvement of PLTP in the stability of atherosclerotic plaque is poorly understood. Our study demonstrates that PLTP adenovirus transduction could destabilize atherosclerotic plaques by reducing collagen and SMC levels and increasing intracellular levels of the cytokines MCP-1, intercellular adhesion molecule-1, and MMP-9 in mouse plaque. Lipid in plaques is an important factor affecting the stability in atherosclerotic plaques. PLTP transduction could promote lipid deposits in mouse plaque and the accumulation of malonaldehyde in macrophages. These data demonstrate the role of PLTP in atherosclerosis under pathophysiological conditions.
In our study, we observed decreased HDL levels in both PLTP −/− ApoE −/− +Ad-GFP and ApoE −/− +Ad-PLTP mice. Many articles have reported similar results. 8, [21] [22] [23] In PLTP deficiency, the blockade of the transfer of phospholipids and cholesterol from triglyceride-rich lipoproteins into HDL may decrease the formation of mature HDL. 24 In PLTP overexpression, because of the facilitated redistribution of phospholipids and cholesterol among lipoproteins, delipidation of HDL was accelerated. 25 Apoptosis is a critical process in the physiological organ development and plays an important role in the pathogenesis of atherosclerosis in terms of stability of plaques, plaque rupture, and thrombosis. 26, 27 We found that PLTP significantly increased the level of inflammatory cytokines and the expression of cleaved caspase-3, involved in apoptosis. NAC treatment of macrophages could reduce the level of inflammatory cytokines and the PLTP-increased expression of cleaved caspase-3. These findings suggest that ROS is involved in regulating PLTP in macrophage apoptosis. ROS are essential mediators of normal cell physiology, but ROS overproduction is associated with inflammation and cell apoptosis. ROS can cause irreversible damage to DNA, proteins, and lipids, thereby altering cell functions. 28 They can inhibit PI3K activity, which reduces RIP3 (receptor interacting protein 3) level and Akt phosphorylation. 29 Growing evidence suggests that reducing ROS production can effectively alleviate inflammatory stress. 30 ROS may be inducers of apoptosis, and antioxidants such as catalase 31 and NAC could delay cell apoptosis. RIP3 was found crucial for tumor necrosis factor-induced apoptosis in experiments with cells lacking RIP3. 32, 33 As well, RIP3 has a proapoptotic role in several cell lines 34 by enhancing caspase activity. Our analysis of the signaling components triggered by PLTP revealed an RIP3-ROS pathway. RIP1-RIP3-dependent ROS production is closely associated with cell death. 35, 36 Vitamin E played a role in antioxidation. PLTP is involved in vitamin E transfer to different lipoproteins and tissues. 12, 37 For example, the bioavailability of vitamin E levels could be regulated by PLTP and protected against the formation of atherosclerotic plaques 38 although most human studies have been negative. 39, 40 Whether vitamin E is involved in PLTP-dependent changes in oxidative is not clear. Apoptosis of macrophages within plaque is an important mechanism leading to atherosclerotic plaque instability. We found that PLTP destabilized atherosclerotic plaque through an RIP3-ROS signal pathway.
In summary, our findings demonstrate that PLTP could promote the aggregation of ROS in macrophages and ROS levels could be elevated by increasing the expression of RIP3. These results reveal an RIP3-ROS signal pathway involved in regulating PLTP in macrophage apoptosis. However, the mechanism of how PLTP intervenes in RIP3 expression remains to be determined. RIP3 recruitment to the nucleus could significantly change the PLTP-increased cleaved caspase-3 level. The relationship between the increased expression of RIP3 and PLTP-induced nucleocytoplasmic shuttling of RIP3 remains for further study. PLTP may play an important role in modulating the stability of atherosclerotic plaques. PLTP increases the apoptosis of cells in plaques, especially macrophages. We also confirm an RIP3-ROS signal pathway and RIP3 localization involved in the PLTP regulation of macrophage apoptosis. Our data bring new insights into a role for PLTP in the stability of atherosclerotic plaques.
